Compile Data Set for Download or QSAR

Found 2 hits of ic50 for monomerid = 50338737   

Target/Host (Institution)	Ligand	Target/Host Links	Ligand Links	Trg + Lig Links	Ki nM	ΔG° kJ/mole	IC50 nM	Kd nM	EC50/IC50 nM	koff s-1	kon M-1s-1	pH	Temp °C
Glucocorticoid receptor (Homo sapiens (Human))	BDBM50338737 ((3R,4S)-5,7-difluoro-6-(1H-indol-7-yl)-2,2,4-trime...) Show SMILES C[C@@H]1[C@@H](OC(=O)Nc2ccccc2)C(C)(C)Nc2cc(F)c(c(F)c12)-c1cccc2cc[nH]c12 |r,wU:2.2,wD:1.0,(20.74,-34.66,;20.74,-36.2,;22.08,-36.98,;23.42,-36.22,;24.75,-36.99,;24.75,-38.53,;26.09,-36.22,;27.42,-37,;27.41,-38.54,;28.74,-39.31,;30.08,-38.54,;30.08,-37,;28.75,-36.23,;22.08,-38.53,;23.62,-38.53,;22.07,-40.07,;20.74,-39.3,;19.41,-38.53,;18.08,-39.3,;16.74,-38.53,;15.41,-39.3,;16.74,-36.99,;18.07,-36.22,;18.07,-34.68,;19.41,-36.98,;15.41,-36.22,;15.42,-34.68,;14.08,-33.91,;12.75,-34.68,;12.76,-36.23,;11.63,-37.27,;12.26,-38.66,;13.78,-38.49,;14.09,-36.99,)| Show InChI InChI=1S/C27H25F2N3O2/c1-15-21-20(32-27(2,3)25(15)34-26(33)31-17-9-5-4-6-10-17)14-19(28)22(23(21)29)18-11-7-8-16-12-13-30-24(16)18/h4-15,25,30,32H,1-3H3,(H,31,33)/t15-,25+/m0/s1	PDB KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet	CHEMBL PC cid PC sid UniChem Similars	Article PubMed	n/a	n/a	40	n/a	n/a	n/a	n/a	n/a	n/a
Ligand Pharmaceuticals Curated by ChEMBL					Assay Description Transrepression activity at GR expressed in IL-1beta- and TNFalpha-stimulated HepG2 cells assessed as inhibition of NFKB- or AP-1 mediated E-selectin...				Bioorg Med Chem Lett 21: 1658-62 (2011) Article DOI: 10.1016/j.bmcl.2011.01.106 BindingDB Entry DOI: 10.7270/Q2VQ32Z4
					More data for this Ligand-Target Pair
Glucocorticoid receptor (Homo sapiens (Human))	BDBM50338737 ((3R,4S)-5,7-difluoro-6-(1H-indol-7-yl)-2,2,4-trime...) Show SMILES C[C@@H]1[C@@H](OC(=O)Nc2ccccc2)C(C)(C)Nc2cc(F)c(c(F)c12)-c1cccc2cc[nH]c12 |r,wU:2.2,wD:1.0,(20.74,-34.66,;20.74,-36.2,;22.08,-36.98,;23.42,-36.22,;24.75,-36.99,;24.75,-38.53,;26.09,-36.22,;27.42,-37,;27.41,-38.54,;28.74,-39.31,;30.08,-38.54,;30.08,-37,;28.75,-36.23,;22.08,-38.53,;23.62,-38.53,;22.07,-40.07,;20.74,-39.3,;19.41,-38.53,;18.08,-39.3,;16.74,-38.53,;15.41,-39.3,;16.74,-36.99,;18.07,-36.22,;18.07,-34.68,;19.41,-36.98,;15.41,-36.22,;15.42,-34.68,;14.08,-33.91,;12.75,-34.68,;12.76,-36.23,;11.63,-37.27,;12.26,-38.66,;13.78,-38.49,;14.09,-36.99,)| Show InChI InChI=1S/C27H25F2N3O2/c1-15-21-20(32-27(2,3)25(15)34-26(33)31-17-9-5-4-6-10-17)14-19(28)22(23(21)29)18-11-7-8-16-12-13-30-24(16)18/h4-15,25,30,32H,1-3H3,(H,31,33)/t15-,25+/m0/s1	PDB KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet	CHEMBL PC cid PC sid UniChem Similars	Article PubMed	n/a	n/a	>1.00E+3	n/a	n/a	n/a	n/a	n/a	n/a
Ligand Pharmaceuticals Curated by ChEMBL					Assay Description Transrepression activity at GR expressed in NHDF cells assessed as IL-1beta-mediated IL-6 transcription by ELISA				Bioorg Med Chem Lett 21: 1658-62 (2011) Article DOI: 10.1016/j.bmcl.2011.01.106 BindingDB Entry DOI: 10.7270/Q2VQ32Z4
					More data for this Ligand-Target Pair